Curcumin-loaded nanomedicines as therapeutic strategy in malaria management

Basit Öğe Kaydı
dc.authoridSharifi-Rad, Javad/0000-0002-7301-8151
dc.authoridAMIN, RUHUL/0000-0001-5329-8152
dc.contributor.authorAmin, Ruhul
dc.contributor.authorDevi, Chanam Melody
dc.contributor.authorSarkar, Dona
dc.contributor.authorSharifi-Rad, Javad
dc.contributor.authorGurer, Eda Sonmez
dc.contributor.authorDocea, Anca Oana
dc.contributor.authorCalina, Daniela
dc.date.accessioned2024-10-26T18:09:51Z
dc.date.available2024-10-26T18:09:51Z
dc.date.issued2023
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractMalaria, a parasitic protozoan disease widespread in tropical climates, is transmitted by Plasmodium spp. Many people are affected by this significant public health disease, which has a high incidence of illness and mortality worldwide. Because drug-resistant parasites are on the rise, there are not enough controls on mosquitoes, and there are not any malaria vaccinations. Malaria is particularly challenging in developing countries. Antimalarial drugs approved by Food and Drug Administration are the main options for combating and preventing malaria; also the control of transmission at the level of mosquitoes is important. Current antimalarial chemotherapeutic therapies have significant clinical flaws such as Plasmodium resistance, the drugs that call for the development of novel drug candidates. To combat malaria, nanotechnology may give a viable alternative that is both more effective and safer than current treatment options. Nanotechnology-based curcumin formulations have proved to overcome the limitations of current therapies in terms of optimum therapeutic benefits, safety, and cost-efficiency, which increases a patient's capacity to adhere to prescribed medicine. The limits of current malaria therapies and the need to employ nanotechnological curcumin to treat malaria were addressed and discussed in this paper.
dc.description.sponsorshipNone
dc.description.sponsorshipNo Statement Available
dc.identifier.doi10.1002/efd2.113
dc.identifier.issn2666-3066
dc.identifier.issue5
dc.identifier.scopus2-s2.0-85171360518
dc.identifier.scopusqualityN/A
dc.identifier.urihttps://doi.org/10.1002/efd2.113
dc.identifier.urihttps://hdl.handle.net/20.500.12418/30296
dc.identifier.volume4
dc.identifier.wosWOS:001134946900003
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofEfood
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectantimalarial
dc.subjectcurcumin
dc.subjectmalaria
dc.subjectnanomedicines
dc.subjectPlasmodium spp
dc.titleCurcumin-loaded nanomedicines as therapeutic strategy in malaria management
dc.typeReview Article

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu